Standout Papers

Guidelines for the Prevention and Treatment of Chronic Hepatitis B (version 2022) 2023 2026 202485
  1. Guidelines for the Prevention and Treatment of Chronic Hepatitis B (version 2022) (2023)
    Hong You, Fu‐Sheng Wang et al. Journal of Clinical and Translational Hepatology

Immediate Impact

8 from Science/Nature 57 standout
Sub-graph 1 of 23

Citing Papers

Global burden of MAFLD, MAFLD related cirrhosis and MASH related liver cancer from 1990 to 2021
2025 Standout
EASL Clinical Practice Guidelines on the management of hepatitis B virus infection
2025 Standout
8 intermediate papers

Works of Yuemin Nan being referenced

Lower end of treatment HBsAg and HBcrAg were associated with HBsAg loss after nucleos(t)ide analog cessation
2023
HBeAg-positive patients with HBsAg  < 100 IU/mL and negative HBV RNA have lower risk of virological relapse after nucleos(t)ide analogues cessation
2021
and 7 more

Author Peers

Author Last Decade Papers Cites
Yuemin Nan 952 630 493 110 1.5k
Qiang Zhu 836 688 568 116 1.9k
Takemi Akahane 726 510 537 106 1.7k
Tetsu Watanabe 704 744 570 59 1.7k
In Hee Kim 591 443 590 94 1.8k
Christophe Van Steenkiste 816 691 428 67 1.6k
Gopal Krishna Dhali 942 562 368 79 1.9k
Neung Hwa Park 952 867 356 94 1.9k
Ryukichi Kumashiro 1039 1164 422 102 2.0k
Xavier Verhelst 875 666 427 102 1.8k
Natalia Rosso 822 352 510 50 1.5k

All Works

Loading papers...

Rankless by CCL
2026